HMGB1 inhibitors significantly inhibit SSLF, which indicates that HMGB1 plays a role in promoting liver fibrosis, though its mechanism is unknown (Vicentino et al., 2018; Chen H. et al., 2021). This evidence concerns the gene HMGB1 and Hepatic fibrosis.